Lunai Bioworks Inc. (RENB) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Lunai Bioworks Inc.

    NASDAQ: RENB · Real-Time Price · USD
    1.42
    0.00 (0.00%)
    At close: Jun 09, 2025, 3:59 PM
    1.54
    8.45%
    After-hours: Sep 30, 2025, 07:59 PM EDT

    Lunai Bioworks Income Statement

    Financials in USD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022
    Revenue
    		 n/a n/a n/a
    Cost of Revenue
    		 n/a 113.5K 123.59K
    Gross Profit
    		 -121.86K -113.5K -123.59K
    Operating Income
    		 -81.64M -38.56M -116.08M
    Interest Income
    		 n/a n/a 122.04K
    Pretax Income
    		 -80.65M -39.68M -113.43M
    Net Income
    		 -80.65M -39.68M -113.43M
    Selling & General & Admin
    		 24.56M 15.32M 14.33M
    Research & Development
    		 2.71M 4.17M 8.37M
    Other Expenses
    		 54.37M n/a n/a
    Operating Expenses
    		 81.64M 19.6M 22.83M
    Interest Expense
    		 1.01M 706.96K 372.84K
    Selling & Marketing Expenses
    		 383.55K n/a n/a
    Cost & Expenses
    		 81.64M 19.6M 22.83M
    Income Tax Expense
    		 n/a n/a 34.00
    Shares Outstanding (Basic)
    		 9.62M 5.63M 5.25M
    Shares Outstanding (Diluted)
    		 9.62M 5.63M 5.25M
    EPS (Basic)
    		 -8.4 -7.1 -21.6
    EPS (Diluted)
    		 -8.4 -7.1 -21.6
    EBITDA
    		 -81.52M -19.48M -22.7M
    EBIT
    		 -79.64M -39.1M -113.06M
    Depreciation & Amortization
    		 121.86K 113.5K 123.59K

    Add to Watchlist